Cel Sci Corporation (CVM)

[GD]

I do not have a calculator, but I have paid a huge tuition to learn
from many many small biotech PIII trials with event delays not from
drug efficacy but from better SOC and better patient selections
that make the control arm patients live much longer than expected.
I have no solid reason for my concern of later reporting results
but my 30 years experience to rely on. There are reasons why CVM
and NWBO CEOs behave very different than all the rest of small
biotech CEOs in report PIII results, they are the only lawyer
small biotech CEOs I have seen, and they behave like a lawyer
but not like a small biotech CEO, they both think street may not
understand their PIII TLD which says a lot about their confidence
of the final results, IMO. By the way, the cheap Mar calls are
my last bet with CVM, if no data news next week, I am gone and
good luck to all CVM longs.